89
We report on 7 patients (2 women, 5 men) with chronic renal failure, who developed under a high dosage of the new diuretic muzolimine (range 240 to 1440 mg per day) fatal neuromyeloencephalopathy.
 7 patients (2 women, 5 men) with chronic renal failure: Subject; chronic renal failure: Subject.Disorder; 7: Subject.Population; fatal neuromyeloencephalopathy: Effect; a high dosage of the new diuretic muzolimine (range 240 to 1440 mg per day): Treatment; diuretic muzolimine: Treatment.Drug; per day: Treatment.Freq; range 240 to 1440 mg: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 7 patients (2 women, 5 men) with chronic renal failure: Subject; chronic renal failure: Subject.Disorder; 7: Subject.Population; fatal neuromyeloencephalopathy: Effect; a high dosage of the new diuretic muzolimine (range 240 to 1440 mg per day): Treatment; diuretic muzolimine: Treatment.Drug; per day: Treatment.Freq; range 240 to 1440 mg: Treatment.Dosage